Sec Form 4 Filing - KANZER STEVE H @ DOR BIOPHARMA INC - 2007-02-09

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person KANZER STEVE H 2. Issuer Name and Ticker or Trading Symbol DOR BIOPHARMA INC [ DOR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 1101 BRICKELL AVENUE, SUITE 701-S 3. Date of Earliest Transaction (MM/DD/YY) 02/09/2007 (Street) MIAMI, FL33131 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock ( 1 ) 02/09/2007 02/09/2007 P 212,766 A $ 0.47 1,282,203 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Options (right to buy) $ 0.58 09/09/2004 09/09/2014 Common Stock 50,000 50,000 D Stock Warrants (right to buy) $ 0.8756 09/15/2003 09/15/2008 Common Stock 125,628 125,628 D Stock Options (right to buy) $ 0.9 09/15/2003 09/15/2013 Common Stock 50,000 50,000 D Stock Options (right to buy) $ 0.58 07/02/2003 07/02/2013 Common Stock 75,000 75,000 D Stock Options (right to buy) $ 1.28 05/01/2003 05/01/2013 Common Stock 75,000 75,000 D Stock Warrants (right to buy) $ 0.75 12/31/2002 12/31/2007 Common Stock 26,609 26,609 D Stock Warrants (right to buy) $ 0.35 12/31/2002 12/31/2007 Common Stock 54,304 54,304 D Stock Warrants (right to buy) $ 0.75 12/31/2002 12/31/2007 Common Stock 142,857 142,857 D Stock Options (right ot buy) $ 0.74 11/29/2001 11/29/2011 Common Stock 167,800 167,800 D Stock Options (right to buy) $ 1.25 02/21/2001 02/21/2011 Common Stock 50,000 50,000 D Stock Options (right to buy) $ 1.375 10/21/1999 10/21/2009 Common Stock 12,000 12,000 D Stock options (right to buy) $ 0.29 01/10/2006 01/10/2016 Common Stock 50,000 50,000 D Stock Options (right to buy) $ 2.4688 10/21/1997 10/21/2007 Common Stock 187,000 187,000 D Stock Options (right to buy) $ 0.425 01/24/2007 01/24/2017 Common Stock 50,000 50,000 D

Reporting Owners Reporting Owner Name / Address Relations hips Director 10% Owner Officer Other KANZER STEVE H 1101 BRICKELL AVENUE SUITE 701-S MIAMI, FL33131 X Signatures /s/ Steve H. Kanzer 02/09/2007 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Private purchase of common stock as part of February 2007 PIPE.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.